RSS0309 Ointment

· Reistone Biopharma Company Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RSS0309 Ointment, covering 2026-01-29 to 2026-01-29. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis [Phase 2]